Matches in Wikidata for { <http://www.wikidata.org/entity/Q73531213> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q73531213 description "article scientifique publié en septembre 2000" @default.
- Q73531213 description "artículu científicu espublizáu en setiembre de 2000" @default.
- Q73531213 description "im September 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73531213 description "scientific article published on 01 September 2000" @default.
- Q73531213 description "wetenschappelijk artikel" @default.
- Q73531213 description "наукова стаття, опублікована у вересні 2000" @default.
- Q73531213 name "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 name "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 type Item @default.
- Q73531213 label "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 label "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 prefLabel "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 prefLabel "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 P1433 Q73531213-E8BB20F5-4199-4814-86BB-3E6617AF993E @default.
- Q73531213 P1476 Q73531213-D72D861C-4ED9-4FC8-B94E-6662BAFBC92A @default.
- Q73531213 P2093 Q73531213-063AB38A-2F04-4872-91A8-F9BD9C459A24 @default.
- Q73531213 P2093 Q73531213-174EFA6C-7396-4A8C-917B-3CECC89E9D28 @default.
- Q73531213 P2093 Q73531213-1D3FC738-4700-43E7-B4AA-BEDBA82B48C0 @default.
- Q73531213 P2093 Q73531213-2D051B9E-C2FD-4D27-B45E-FDC633A8B9C1 @default.
- Q73531213 P2093 Q73531213-36E75D5C-4BF0-42F1-A4D0-521BC0785B9F @default.
- Q73531213 P2093 Q73531213-371C515F-4C74-4F15-A519-123BC88720A1 @default.
- Q73531213 P2093 Q73531213-6A901FF4-DE7F-4752-8BC5-993F17139691 @default.
- Q73531213 P2093 Q73531213-74E1DF1C-6802-454C-A093-B9E8C4BB720B @default.
- Q73531213 P2093 Q73531213-E02A9812-9E6D-4329-AA14-E3C86E7D5BA3 @default.
- Q73531213 P2093 Q73531213-FDE59B57-D533-4E6F-BFA1-AF8128F0603F @default.
- Q73531213 P304 Q73531213-819C1EEC-D324-4543-8C9A-AAE6BAE4A5BB @default.
- Q73531213 P31 Q73531213-A69A6FE9-09DC-4EEA-9C6B-6E4DA4E8758C @default.
- Q73531213 P433 Q73531213-36A827AF-42D3-43C4-94F7-C2D7B0DB75B2 @default.
- Q73531213 P478 Q73531213-E74F3E4C-10F7-4E62-A6CF-DF3B01E0F1B0 @default.
- Q73531213 P577 Q73531213-4BA0A0EB-02AF-4587-BED5-1DA90092D78F @default.
- Q73531213 P698 Q73531213-32E0837E-8F6D-4811-885D-FCB4D903A951 @default.
- Q73531213 P698 11214999 @default.
- Q73531213 P1433 Q45115475 @default.
- Q73531213 P1476 "[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]" @default.
- Q73531213 P2093 "A Kuga" @default.
- Q73531213 P2093 "H Kitasato" @default.
- Q73531213 P2093 "I Seto" @default.
- Q73531213 P2093 "K Hoshino" @default.
- Q73531213 P2093 "M Hosaka" @default.
- Q73531213 P2093 "M Inoue" @default.
- Q73531213 P2093 "R Okamoto" @default.
- Q73531213 P2093 "S Kaieda" @default.
- Q73531213 P2093 "T Eda" @default.
- Q73531213 P2093 "Y Sato" @default.
- Q73531213 P304 "593-608" @default.
- Q73531213 P31 Q13442814 @default.
- Q73531213 P433 "9" @default.
- Q73531213 P478 "53" @default.
- Q73531213 P577 "2000-09-01T00:00:00Z" @default.
- Q73531213 P698 "11214999" @default.